Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

Inhibrx Q2 EPS $(1.08) Down From $(0.97) YoY, Sales $30.00K Down From $711.00K YoY

Author: Benzinga Newsdesk | August 07, 2023 04:21pm
Inhibrx (NASDAQ:INBX) reported quarterly losses of $(1.08) per share. This is a 11.34 percent decrease over losses of $(0.97) per share from the same period last year. The company reported $30.00 thousand in sales this quarter. This is a 95.78 percent decrease over sales of $711.00 thousand the same period last year.

Posted In: INBX


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist